跳轉至內容
Merck
全部照片(1)

重要文件

246212

Sigma-Aldrich

4-苄氧基吲哚

98%

同義詞:

NSC 92539

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C15H13NO
CAS號碼:
分子量::
223.27
EC號碼:
MDL號碼:
分類程式碼代碼:
12352100
PubChem物質ID:
暫時無法取得訂價和供貨情況

化驗

98%

mp

57-61 °C (lit.)

官能基

phenyl

SMILES 字串

C(Oc1cccc2[nH]ccc12)c3ccccc3

InChI

1S/C15H13NO/c1-2-5-12(6-3-1)11-17-15-8-4-7-14-13(15)9-10-16-14/h1-10,16H,11H2

InChI 密鑰

LJFVSIDBFJPKLD-UHFFFAOYSA-N

應用

4-Benzyloxyindole was used in the synthesis of 4-alkyloxy-aminoalkyl indole derivatives[1].
  • Reactant for regioselective synthesis of oxopyrrolidine analogs via iodine-catalyzed Markovnikov addition
  • Reactant for preparation of indoles by Bartoli reductive cyclization as useful intermediates in medicinal chemistry research
  • Reactant for synthesis of carbon-11-labeled 4-aryl-4H-chromenes as new PET agents for imaging of apoptosis in cancer
  • Reactant for preparation of HCV inhibitors
  • Reactant for preparation of indol-3-yl tetramethylcyclopropyl ketones as CB2 cannabinoid receptor ligands
  • Reactant for preparation of 4-aryl-4H-chromenes as apoptosis inducers

象形圖

Exclamation mark

訊號詞

Warning

危險聲明

危險分類

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

標靶器官

Respiratory system

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

dust mask type N95 (US), Eyeshields, Gloves


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

未看到正確版本?

如果您需要一個特定的版本,您可以透過批號來尋找特定憑證。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

A K Dutta et al.
Bioorganic & medicinal chemistry, 5(8), 1591-1600 (1997-08-01)
Several novel 4-alkyloxy-aminoalkyl indole derivatives 3 were synthesized from 4-benzyloxyindole (1). Alkylation of 1 with 4-(2-chloroethyl)morpholine (NaH/HMPA) formed 2. Deprotection using palladium hydroxide on carbon/hydrogen followed by alkylation with the appropriate alkyl bromide gave the target compounds 3b-3j. In the
Ruinan Yang et al.
The Journal of pharmacology and experimental therapeutics, 370(3), 864-875 (2019-04-19)
Castration-resistant prostate cancer that has become resistant to docetaxel (DTX) represents one of the greatest clinical challenges in the management of this malignancy. There is an urgent need to develop novel therapeutic agents to overcome chemoresistance and improve the overall

Questions

Reviews

No rating value

Active Filters

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務